Cytokinetics (CYTK) earnings

Earnings (net income) · fiscal 2025
-$784.96M

Cytokinetics (CYTK) reported net income of -$784.96M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$589.53M. Figures as of 18 Nov 2026, 08:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$784.96M
Highest on record
$24.54Mfiscal 2009
Lowest on record
-$784.96Mfiscal 2025
Fiscal years on record
271999–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cytokinetics earnings, in more detail

Across the 27 fiscal years on record (1999–2025), the highest was $24.54M in fiscal 2009 and the lowest -$784.96M in fiscal 2025.

History · 27 fiscal years

Earnings (net income) by fiscal year

Cytokinetics earnings, year by year

Cytokinetics (CYTK) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$784.96M—
2024-$589.53M—
2023-$526.24M—
2022-$388.96M—
2021-$215.31M—
2020-$127.29M—
2019-$121.69M—
2018-$106.29M—
2017-$127.79M 876.7% down
2016$16.45M—
2015-$37.50M—
2014-$14.65M—
2013-$33.72M—
2012-$40.37M—
2011-$47.86M—
2010-$49.29M 300.8% down
2009$24.54M—
2008-$56.37M—
2007-$48.89M—
2006-$57.12M—
2005-$42.25M—
2004-$37.20M—
2003-$32.69M—
2002-$23.08M—
2001-$15.87M—
2000-$13.08M—
1999-$7.34M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Cytokinetics and comparable companies
CompanyEarnings (net income)Fiscal year
Cytokinetics CYTK-$784.96M2025
ABIVAX ABVX-€336.10M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CYTK

Cytokinetics, figure by figure

Cytokinetics (CYTK) overview: price, valuation and scorecardAll health care companies by market value

Cytokinetics earnings: questions and answers

What is Cytokinetics's net income?

Cytokinetics (CYTK) reported net income of -$784.96M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$589.53M.

What are the highest and lowest net income figures on record for Cytokinetics?

Across the 27 fiscal years on record (1999–2025), the highest was $24.54M in fiscal 2009 and the lowest -$784.96M in fiscal 2025.

How is Cytokinetics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytokinetics (CYTK) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/CYTK/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.